Publication: Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy
Loading...
Open/View Files
Date
2018
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media S.A.
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Fusco, D. N., L. Ganova-Raeva, Y. Khudyakov, L. Punkova, A. Mohamed, S. S. Y. Cheon, P. Koirala, et al. 2018. “Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy.” Frontiers in Medicine 5 (1): 97. doi:10.3389/fmed.2018.00097. http://dx.doi.org/10.3389/fmed.2018.00097.
Abstract
A 76-year-old Cambodian man co-infected with hepatitis B virus (HBV) and hepatitis C virus (HCV) 6c-1 presented for care. HBV DNA was intermittently detectable despite anti-HBs levels being above the protective threshold. During treatment for HCV, HBV DNA levels increased. Sequencing revealed multiple mutations including vaccine escape mutation and mutations predicted to enhance fitness. This case represents exacerbation of an HBV vaccine escape mutant during a direct-acting antiviral therapy.
Description
Other Available Sources
Research Data
Keywords
Case Report, hepatitis B virus, preS2 deletion, surface antibody escape mutant, HBV vaccine escape mutant, HCV
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service